Health - Latest News Search Engine - Global and Local Breaking News

Health

Microtech ogłasza pierwsze zabiegi wszczepienia mikroczujników do przedsionka serca w ramach badania FIH w USA

TEL AWIW, Izrael, 9 czerwca 2025 r. /PRNewswire/ - Microtech, podmiot zależny należący w całości do spółki Medinol, z radością ogłasza pierwsze wszcze...

Microtech ogłasza pierwsze zabiegi wszczepienia mikroczujników do przedsionka serca w ramach badania FIH w USA

Microtech oznamuje prvé implantácie predsieňových mikrosenzorov v USA v rámci štúdie FIH

TEL AVIV, Izrael, 9. jún 2025 /PRNewswire/ – Spoločnosť Microtech, stopercentná dcérska spoločnosť Medinol, s radosťou oznamuje prvé implantácie svojh...

Microtech oznamuje prvé implantácie predsieňových mikrosenzorov v USA v rámci štúdie FIH

Microtech объявляет о первой в США имплантации микродатчика предсердий в рамках проводимого компанией FIH-исследования

ТЕЛЬ-АВИВ, Израиль, 9 июня 2025 г. /PRNewswire/ -- Microtech, находящаяся в полной собственности дочерняя компания Medinol, рада объявить о первой в С...

Microtech объявляет о первой в США имплантации микродатчика предсердий в рамках проводимого компанией FIH-исследования

H.I.G. Capital Completes Acquisition of ITH Group Limited

LONDON, June 9, 2025 /PRNewswire/ -- H.I.G. Capital ("H.I.G."), a leading global alternative investment firm with $70 billion of capital under managem...

H.I.G. Capital Completes Acquisition of ITH Group Limited

TORL BioTherapeutics Announces Appointment of Anna Berkenblit, MD, MMSc, as Board Member

LOS ANGELES, June 9, 2025 /PRNewswire/ -- TORL BioTherapeutics LLC (TORL), a clinical-stage biotechnology company discovering and developing new antib...

TORL BioTherapeutics Announces Appointment of Anna Berkenblit, MD, MMSc, as Board Member

Microtech anuncia los primeros implantantes de microsensores auriculares en EE UU.

-Microtech anuncia los primeros implantantes de microsensores auriculares en EE UU. como parte de su estudio FIH TEL AVIV, Israel, 9 de junio de 2025 ...

Microtech anuncia los primeros implantantes de microsensores auriculares en EE UU.

Microtech annonce les premières implantations de microcapteurs auriculaires aux États-Unis dans le cadre de son étude FIH

TEL AVIV, Israël, 9 juin 2025 /PRNewswire/ -- Microtech, filiale à 100 % de Medinol, est heureuse d'annoncer les premières implantations aux États-Uni...

Microtech annonce les premières implantations de microcapteurs auriculaires aux États-Unis dans le cadre de son étude FIH

NHS calls for 200,000 new blood donors as supplies run low

The health service issued an "amber alert" last year and stocks remain low ever since.

NHS calls for 200,000 new blood donors as supplies run low

Nurses to vote on pay deal as potential strike looms

The ballot is being billed by representatives as the biggest single vote by the profession in the UK.

Nurses to vote on pay deal as potential strike looms

耶穌基督後期聖徒教會加強全球努力，將最初的捐贈預算翻倍，幫助改善全球超過 2,100 萬名婦女和兒童的生活

鹽湖城2025年6月9日 /美通社/ -- 耶穌基督後期聖徒教會 (The Church of Jesus Christ of Latter-day Saints) 一直肩負著照顧有需要的人的責任，為了改善婦女與兒童的福祉，教會正在加強其全球倡議。 2025 年 6 月 5 日（星期四）在猶他州鹽湖...

耶穌基督後期聖徒教會加強全球努力，將最初的捐贈預算翻倍，幫助改善全球超過 2,100 萬名婦女和兒童的生活

Hansa Biopharma to Host Science Deep Dive Virtual Investor Event on Guillain-Barré Syndrome on June 16, 2025

LUND, Sweden, June 9, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced that it will host a virtual investor e...

Hansa Biopharma to Host Science Deep Dive Virtual Investor Event on Guillain-Barré Syndrome on June 16, 2025

Everest Medicines Presents Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of Novel BTK Inhibitor EVER001 at the 62nd Congress ...

EVER001 is a covalent reversible BTK inhibitor with potentially best-in-class characteristics for the treatment of primary membranous nephropathy (pMN...

Everest Medicines Presents Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of Novel BTK Inhibitor EVER001 at the 62nd Congress of the European Renal Association

28bio Announces Nexon™ Neurotechnology Platform Powered by Engineered Human Brains

Exhibits complex neurological processes—including memory, learning, and cognition—and predicts human outcomes in preclinical drug development NEW ORLE...

28bio Announces Nexon™ Neurotechnology Platform Powered by Engineered Human Brains

Ascletis Announces Poster Presentations on the Study Results of ASC30 and ASC47 at the 85th Scientific Sessions of American Diabetes Association (ADA)...

HONG KONG, June 8, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that poster presentations on preliminary studies of it...

Ascletis Announces Poster Presentations on the Study Results of ASC30 and ASC47 at the 85th Scientific Sessions of American Diabetes Association (ADA)

Doctors trialling 'poo pills' to flush out dangerous superbugs

Can a dose of good bacteria clear superbugs from their hiding place in the bowels?

Doctors trialling 'poo pills' to flush out dangerous superbugs

耶稣基督的教会加强全球努力，将最初的预测增加一倍，帮助改善全球2100多万妇女和儿童的生活

盐湖城2025年6月7日 /美通社/ -- 作为持续关爱有需要人士的责任的一部分，耶稣基督后期圣徒教会正在支持其改善妇女和儿童福祉的全球倡议。在2025年6月5日星期四于犹他州盐湖城圣殿广场举行的会议上，总会长卡米尔•约翰逊告诉来自八个全球人道主义组织的代表，教会将向这个于2023年首次宣布的...

耶稣基督的教会加强全球努力，将最初的预测增加一倍，帮助改善全球2100多万妇女和儿童的生活

La Iglesia de Jesucristo fortalece el esfuerzo global, duplicando las proyecciones iniciales, ayudando a mejorar las vidas de más de 21 millones de mu...

SALT LAKE CITY, 7 de junio de 2025 /PRNewswire-HISPANIC PR WIRE/ -- Como parte de su continua responsabilidad de cuidar a los necesitados, La Iglesia ...

La Iglesia de Jesucristo fortalece el esfuerzo global, duplicando las proyecciones iniciales, ayudando a mejorar las vidas de más de 21 millones de mujeres y niños en todo el mundo

We always joked dad looked nothing like his parents - then we found out why

Matthew's father died late last year - before learning the truth about his family history.

We always joked dad looked nothing like his parents - then we found out why

The Church of Jesus Christ strengthens global effort, doubling initial projections, helping improve the lives of more than 21 million women and childr...

SALT LAKE CITY , June 6, 2025 /PRNewswire/ -- As part of its ongoing responsibility to care for those in need, The Church of Jesus Christ of Latter-da...

The Church of Jesus Christ strengthens global effort, doubling initial projections, helping improve the lives of more than 21 million women and children worldwide

The British Medical Journal Publishes Study Results on Sacituzumab Tirumotecan for Previously Treated EGFR-Mutant Advanced NSCLC

CHENGDU, China, June 6, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", 6990.HK) today announced that results...

The British Medical Journal Publishes Study Results on Sacituzumab Tirumotecan for Previously Treated EGFR-Mutant Advanced NSCLC